Recent advances in management of MI

Recently the reperfusion therapy in the form of Primary Percutaneous Coronary intervention (PPCI) has become the gold standard for the treatment of Acute Myocardial Infarction. In spite of rapid revascularization either with PPCI or thrombolytic therapy the significant number of patients develops decreased left ventricular function leading to heart failure which can increase long term mortality and morbidity.